Large-scale testing (Phase 3)Not Yet RecruitingNCT06898060
What this trial is testing
To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture
Who this might be right for
Postmenopausal Women With Osteoporosis
Qilu Pharmaceutical Co., Ltd. 282